
About Pharmsville
Pharmsville is a publicly listed company based in Seoul (South Korea) founded in 2000. Nutraceutical products are manufactured by Pharmsville in Seoul. The company has 36 employees. Its chief executive, as recorded, is Byung Wook Lee. Its focus areas include Traditional Nutraceuticals and Diversified.
Company details
Pharmsville was established in 2000 and is located in Seoul, South Korea. Operations are centered on the nutraceutical sector, where a range of health-focused products are produced. The company is led by CEO and President Byung Wook Lee. Manufacturing activities are conducted to meet industry standards, with distribution handled primarily in the domestic market. Details on specific product lines or expansions are not publicly detailed.
- Headquarters Seoul, South Korea
- Employees 36
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website pharmsville.net
- Legal Name Pharmsville Co., Ltd.
- Annual Revenue$8.81 M (USD)-23.9as on Dec 31, 2025
- Net Profit$2 M (USD)82.47as on Dec 31, 2025
- EBITDA-$84.78 K (USD)-138.56as on Dec 31, 2025
- Employee Count36
People of Pharmsville
1 people are tracked at Pharmsville (1 in leadership); the tracked headcount is 36.
| Name | Role | Group |
|---|---|---|
Byung Wook Lee | CEO & President | Leadership |
Complete people profiles for Pharmsville
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Pharmsville
Pharmsville is a publicly listed company on the KRX with ticker symbol 318010 in South Korea, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Oct 2019
- Listed onKRX: 318010
- Listed entityPharmsville Co., Ltd.
- Exchange sectorRetail trade
- ISINKR7318010006
- Share price3,505.00 KRW (+0.86% on the day) · 2026-10-14
- Market capitalisation26,855,209,851.00 KRW
- Price to earnings9.1
- EPS (diluted, trailing year)386.80 KRW
- Dividend yield5.68%
- Volume (last session)121
Financials of Pharmsville
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 12.73B KRW | 2.89B KRW | -122.4M KRW |
| 2024 | 16.72B KRW | 1.58B KRW | 317.5M KRW |
| 2023 | 21.39B KRW | 3.31B KRW | 2.23B KRW |
| 2022 | 26.11B KRW | 4.06B KRW | 4.65B KRW |
| 2021 | 39.03B KRW | 5.00B KRW | 6.28B KRW |
Detailed financial statements for Pharmsville
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Pharmsville
Websites that share an audience with Pharmsville (pharmsville.net).
Websites whose visitors overlap most with Pharmsville. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| i-appletree.com | 100% | #2,737,683 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmsville
Pharmsville was founded in 2000.
Pharmsville is headquartered in Seoul, South Korea.
Byung Wook Lee is the CEO of Pharmsville, as recorded in our data.
Pharmsville has 36 employees.
Annual revenue of Pharmsville is $8.81M as on Dec 31, 2025.
Pharmsville was established in 2000 and is located in Seoul, South Korea. Operations are centered on the nutraceutical sector, where a range of health-focused products are produced. The company is led by CEO and President Byung Wook Lee. Manufacturing activities are conducted to meet industry standards, with distribution handled primarily in the domestic market. Details on specific product lines or expansions are not publicly detailed.
Yes, Pharmsville is publicly traded on KRX under the ticker symbol 318010.